BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 15548844)

  • 1. In silico approaches for predicting ADME properties of drugs.
    Yamashita F; Hashida M
    Drug Metab Pharmacokinet; 2004 Oct; 19(5):327-38. PubMed ID: 15548844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
    van de Waterbeemd H
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico ADME-Tox modeling: progress and prospects.
    Alqahtani S
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving early drug discovery through ADME modelling: an overview.
    Wishart DS
    Drugs R D; 2007; 8(6):349-62. PubMed ID: 17963426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-silico ADME models: a general assessment of their utility in drug discovery applications.
    Gleeson MP; Hersey A; Hannongbua S
    Curr Top Med Chem; 2011; 11(4):358-81. PubMed ID: 21320065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting ligand interactions with ABC transporters in ADME.
    Demel MA; Krämer O; Ettmayer P; Haaksma EE; Ecker GF
    Chem Biodivers; 2009 Nov; 6(11):1960-9. PubMed ID: 19937827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADMET in silico modelling: towards prediction paradise?
    van de Waterbeemd H; Gifford E
    Nat Rev Drug Discov; 2003 Mar; 2(3):192-204. PubMed ID: 12612645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-ADME relationship: still a long way to go?
    Hou T; Wang J
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):759-70. PubMed ID: 18611116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging importance of predictive ADME simulation in drug discovery.
    Selick HE; Beresford AP; Tarbit MH
    Drug Discov Today; 2002 Jan; 7(2):109-16. PubMed ID: 11790621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models.
    Hop CE; Cole MJ; Davidson RE; Duignan DB; Federico J; Janiszewski JS; Jenkins K; Krueger S; Lebowitz R; Liston TE; Mitchell W; Snyder M; Steyn SJ; Soglia JR; Taylor C; Troutman MD; Umland J; West M; Whalen KM; Zelesky V; Zhao SX
    Curr Drug Metab; 2008 Nov; 9(9):847-53. PubMed ID: 18991580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the Internet help to meet the challenges in ADME and e-ADME?
    Van de Waterbeemd H; De Groot M
    SAR QSAR Environ Res; 2002; 13(3-4):391-401. PubMed ID: 12184380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.
    Khakar PS
    Curr Top Med Chem; 2010; 10(1):116-26. PubMed ID: 19929825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in predicting human ADME parameters in silico.
    Ekins S; Waller CL; Swaan PW; Cruciani G; Wrighton SA; Wikel JH
    J Pharmacol Toxicol Methods; 2000; 44(1):251-72. PubMed ID: 11274894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico methods to predict drug toxicity.
    Roncaglioni A; Toropov AA; Toropova AP; Benfenati E
    Curr Opin Pharmacol; 2013 Oct; 13(5):802-6. PubMed ID: 23797035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting ADME properties in silico: methods and models.
    Butina D; Segall MD; Frankcombe K
    Drug Discov Today; 2002 Jun; 7(11):S83-8. PubMed ID: 12047885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In-silico prediction of pharmacokinetic properties].
    Hashida M
    Yakugaku Zasshi; 2005 Nov; 125(11):853-61. PubMed ID: 16272806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools.
    Tao L; Zhang P; Qin C; Chen SY; Zhang C; Chen Z; Zhu F; Yang SY; Wei YQ; Chen YZ
    Adv Drug Deliv Rev; 2015 Jun; 86():83-100. PubMed ID: 26037068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico prediction of cytochrome P450-mediated drug metabolism.
    Zhang T; Chen Q; Li L; Liu LA; Wei DQ
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):388-95. PubMed ID: 21470181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
    Honório KM; Moda TL; Andricopulo AD
    Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.